Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
105.88
-2.13 (-1.97%)
At close: Nov 21, 2025, 4:00 PM EST
107.94
+2.06 (1.95%)
After-hours: Nov 21, 2025, 6:12 PM EST
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $7.7 billion as of November 21, 2025. Its market cap has increased by 15.97% in one year.
Market Cap
7.70B
Enterprise Value
6.76B
1-Year Change
15.97%
Ranking
Category
Stock Price
$105.88
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $7.70B, an increase of 867.15%. That is a compound annual growth rate of 69.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 7.70B | 38.41% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
| Jul 29, 2021 | 795.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 949.84B |
| Johnson & Johnson | 495.52B |
| AbbVie | 420.12B |
| UnitedHealth Group | 291.31B |
| AstraZeneca | 280.49B |
| Merck & Co. | 247.06B |
| Novartis AG | 239.24B |
| Abbott Laboratories | 223.36B |